Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $32.3200 (-1.94%) ($29.6800 - $33.2240) on Fri. Jul. 29, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.42% (three month average) | RSI | 45 | Latest Price | $32.3200(-1.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -0.5% a day on average for past five trading days. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(8%) UUP(6%) ICLN(5%) ARKG(4%) ARKK(4%) | Factors Impacting EYES price | EYES will decline at least -2.71% in a week (0% probabilities). BND(-7%) BNDX(-5%) XLU(-4%) VCSH(-4%) VCIT(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.71% (StdDev 5.42%) | Hourly BBV | 0 () | Intraday Trend | 2.3% | | | |
|
5 Day Moving Average | $33.1(-2.36%) | 10 Day Moving Average | $32.91(-1.79%) | 20 Day Moving Average | $32.16(0.5%) | To recent high | -14.6% | To recent low | 27% | Market Cap | $10.323b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |